WallStreetZenWallStreetZen

AnalystsWilliam Plovanic
William Plovanic's Stock Forecasts

Analyst Ranking
Bottom 11%
#3677 out of 4119 analysts
Average Return
-9.6%
Win Rate
32%9 out of 28
Risk vs Reward
Poor
Good

William Plovanic's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Transmedics Group IncTMDX
+179.07%$22.17$61.87
2022-03-17 -
2022-11-30
Strong Buy
Shockwave Medical IncSWAV
+49.61%$130.26$194.88
2021-03-31 -
2022-03-30
Strong Buy
Merit Medical Systems IncMMSI
+31.58%$54.72$72.00
2022-10-14 -
2022-11-30
Strong Buy
Shockwave Medical IncSWAV
+28.19%$120.94$155.03
2021-02-02 -
2022-02-01
Strong Buy
Penumbra IncPEN
+25.58%$166.83$209.51
2022-08-05 -
2022-11-30
Strong Buy

William Plovanic's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Atricure IncATRC
4Strong Buy$65.00+42.67%Maintains
a month ago
Staar Surgical CoSTAA
1Strong Buy$88.00+54.09%Maintains
2 months ago
Merit Medical Systems IncMMSI
2Strong Buy$63.00-12.50%Maintains
2 months ago
Edwards Lifesciences CorpEW
4Hold$91.00+17.80%Maintains
2 months ago
Inari Medical IncNARI
3Strong Buy$94.00+27.75%Maintains
3 months ago
Irhythm Technologies IncIRTC
2Strong Buy$198.00+81.57%Maintains
3 months ago
Penumbra IncPEN
1Strong Buy$189.00-9.79%Maintains
4 months ago
Boston Scientific CorpBSX
1Strong Buy$43.00-5.01%Maintains
5 months ago
Vapotherm IncVAPO
2Hold$5.00+461.80%Downgrades
7 months ago
Transmedics Group IncTMDX
1Strong Buy$39.00-36.96%Maintains
8 months ago
Acutus Medical IncAFIB
4Hold$3.00+270.37%Downgrades
a year ago
Nevro CorpNVRO
3Hold$97.00+107.66%Maintains
a year ago
Angiodynamics IncANGO
1Strong Buy$37.00N/AUpgrades
a year ago
Pulmonx CorpLUNG
2Strong Buy$53.00N/AMaintains
a year ago
Cvrx IncCVRX
1Strong Buy$30.00N/AInitiates Coverage On
a year ago
Shockwave Medical IncSWAV
3Strong Buy$202.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.